Casirivimab and imdevimab as investigational monoclonal antibodies for COVID-19 patients – review of the literature

.blurhash-client-img { display: none !important; }

Open Access

|Oct 2021

Authors

Students’ Scientific Association of Chair and Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland

Students’ Scientific Association of Chair and Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland

Students’ Scientific Association of Chair and Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland

Students’ Scientific Association of Chair and Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland

Chair and Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland

DOI: https://doi.org/10.2478/cipms-2021-0030 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Language: English

Page range: 138 - 141

Submitted on: Mar 29, 2021

Accepted on: Aug 20, 2021

Published on: Oct 8, 2021

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2021 Gabriela Reka, Angelika Pawlak, Piotr Machowiec, Marcela Maksymowicz, Halina Piecewicz-Szczesna, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.